LYMPHOID NEOPLASIA Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma

نویسندگان

  • Jose A. Richter-Larrea
  • Eloy F. Robles
  • Vicente Fresquet
  • Elena Beltran
  • Antonio J. Rullan
  • Xabier Agirre
  • Maria José Calasanz
  • Carlos Panizo
  • Jose A. Richter
  • Jesus M. Hernandez
  • Jose Roman-Gomez
  • Felipe Prosper
  • Jose A. Martinez-Climent
چکیده

1Division of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona, Spain; 2Department of Genetics, University of Navarra, Pamplona, Spain; 3 Hematology & Cell Therapy Programs, Clinica Universidad de Navarra, Pamplona, Spain; 4Department of Nuclear Medicine, Clinica Universidad de Navarra, Pamplona, Spain; 5Department of Hematology, Hospital Universitario and Center of Cancer Research, University of Salamanca-CSIC, Salamanca, Spain; and 6Department of Hematology, Reina Sofia Hospital, Maimonides Institute for Biomedical Research, Cordoba, Spain

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.

In Burkitt lymphoma/leukemia (BL), achievement of complete remission with first-line chemotherapy remains a challenging issue, as most patients who respond remain disease-free, whereas those refractory have few options of being rescued with salvage therapies. The mechanisms underlying BL chemoresistance and how it can be circumvented remain undetermined. We previously reported the frequent inac...

متن کامل

LYMPHOID NEOPLASIA KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma

The transcription factor KLF4 may act both as an oncogene and a tumor suppressor in a tissue-depending manner. In Tand pre-B-cell lymphoma, KLF4 was found to act as tumor suppressor. We found the KLF4 promoter methylated in B-cell lymphoma cell lines and in primary cases of B-cell lymphomas, namely, follicular lymphoma, diffuse large B-cell lymphoma, Burkitt lymphoma, and in classic Hodgkin lym...

متن کامل

Structural Basis for Apoptosis Inhibition by Epstein-Barr Virus BHRF1

Epstein-Barr virus (EBV) is associated with human malignancies, especially those affecting the B cell compartment such as Burkitt lymphoma. The virally encoded homolog of the mammalian pro-survival protein Bcl-2, BHRF1 contributes to viral infectivity and lymphomagenesis. In addition to the pro-apoptotic BH3-only protein Bim, its key target in lymphoid cells, BHRF1 also binds a selective sub-se...

متن کامل

Central Nervous System Burkitt Lymphoma in a child (A case report).

Introduction: Burkitt lymphoma (BL) is rare, but an aggressive malignancy. Central nervous system Burkitt lymphoma (CNSBL) is very rare. CNS Burkitt’s lymphoma is treated with high-dose chemotherapy and radiation. Radiotherapy in children younger than three years old may cause major CNS damage. Case report: A three-year-old boy presented with painful proptosis of the left eye. He under...

متن کامل

Role of Stem Cell Transplantation in the Treatment of Burkitt Lymphoma; A Systematic Review

Background: Burkitt lymphoma is a common subtype of non-Hodgkin lymphoma in children. It has a rapid and aggressive clinical course with frequent involvement of bone marrow and central nervous system. Systemic chemotherapy is the mainstay of the treatment for this malignancy in children. In this systematic review, we discuss autologous and allogeneic hematopoietic stem cell transplantation (HSC...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010